OverviewSuggest Edit

Axxam is a contract research and discovery company. Its capabilities and expertise include molecular biology (cloning, gene expression analysis, protein expression, genomic engineering), assay development and reagent provision (cellular and biochemical systems), as well as compound management. The company also specializes in fully automated high-throughput screening, hit characterization and profiling, cardiac safety and liability profiling, and electrophysiology.
TypePrivate
Founded2001
HQBresso, IT
Websiteaxxam.com

Latest Updates

Employees (est.) (Jun 2021)144(+3%)
Cybersecurity ratingBMore

Key People/Management at Axxam

Luigi Gavazzeni

Luigi Gavazzeni

Chief Financial Officer
Silvia Bottinelli

Silvia Bottinelli

Director Human Resources
Lia Scarabottolo

Lia Scarabottolo

Director Discovery Services
Sabrina Corazza

Sabrina Corazza

Director Business Development
Chiara Liberati

Chiara Liberati

Director Discovery Research
Stefan Lohmer

Stefan Lohmer

Chairman and CEO
Show more

Axxam Office Locations

Axxam has offices in Bresso, Napoli and Konstanz
Bresso, IT (HQ)
Via Antonio Meucci, 3
Napoli, IT
Via Pietro Castellino, 111
Konstanz, DE
Byk-Gulden-Straße 2
Show all (3)

Axxam Financials and Metrics

Summary Metrics

Founding Date

2001

Axxam total Funding

$340 k

Axxam latest funding size

$340 k

Time since last funding

6 years ago
Axxam's latest funding round in January 2015 was reported to be $340 k. In total, Axxam has raised $340 k
Show all financial metrics

Axxam Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Axxam Online and Social Media Presence

Embed Graph

Axxam Blogs

Axxam is a member of the REsolution consortium

Axxam announces its participation in the REsolution consortium, a public-private research partnership supported by the Innovative Medicines Initiative (IMI), to accelerate research in the field of solute carrier (SLC) class of transporters. L'articolo Axxam is a member of the REsolution consortium p…

Axxam acquires Hit Discovery Constance

Axxam is proud to announce the entire acquisition of the share capital of Hit Discovery Constance GmbH (“HDC”). As a consequence, HDC founded in 2014 as a joint venture between Axxam, Centre for Drug Design and Discovery of KU Leuven and Lead Discovery Center GmbH, is now a subsidiary of Axxam. L'a…

Symegold library for drug discovery services

Thanks to the long-standing collaboration with Symeres (recently rebranded from MercachemSyncom), Axxam has access to an additional library of approx. 80,000 lead-like compounds synthetized at Symeres, named Symegold library, for use in high-throughput screens. L'articolo Symegold library for drug d…

Molecular interactions in drug discovery programs

22 October 2020 11:00 & 17:30 CEST L'articolo Molecular interactions in drug discovery programs proviene da AXXAM.

Biotech & Pharma VirtualPartnering Conference 2020

28-30 September 2020 Digitally Delivered L'articolo Biotech & Pharma Virtual<br/>Partnering Conference 2020 proviene da AXXAM.

BIO International ConventionVirtual Attendance

8-12 June 2020 San Diego, USA L'articolo BIO International Convention<br/>Virtual Attendance proviene da AXXAM.
Show more

Axxam Frequently Asked Questions

  • When was Axxam founded?

    Axxam was founded in 2001.

  • Who are Axxam key executives?

    Axxam's key executives are Luigi Gavazzeni, Silvia Bottinelli and Lia Scarabottolo.

  • How many employees does Axxam have?

    Axxam has 144 employees.

  • Who are Axxam competitors?

    Competitors of Axxam include Cyprotex, Alcami and Biovian.

  • Where is Axxam headquarters?

    Axxam headquarters is located at Via Antonio Meucci, 3, Bresso.

  • Where are Axxam offices?

    Axxam has offices in Bresso, Napoli and Konstanz.

  • How many offices does Axxam have?

    Axxam has 3 offices.